These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18785602)

  • 41. Meta-analysis of the risk of upper gastrointestinal hemorrhage with combination therapy of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs.
    Oka Y; Okamoto K; Kawashita N; Shirakuni Y; Takagi T
    Biol Pharm Bull; 2014; 37(6):947-53. PubMed ID: 24681541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bipolar disorder with Asperger's disorder.
    Duggal HS
    Am J Psychiatry; 2003 Jan; 160(1):184-5. PubMed ID: 12505825
    [No Abstract]   [Full Text] [Related]  

  • 43. Antidepressant use and risk of adverse outcomes in people aged 20-64 years: cohort study using a primary care database.
    Coupland C; Hill T; Morriss R; Moore M; Arthur A; Hippisley-Cox J
    BMC Med; 2018 Mar; 16(1):36. PubMed ID: 29514662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypothesis: antiplatelet effects of selective serotonin reuptake inhibitors cause clinical benefits on cardiovascular disease and increase risks of bleeding.
    Serebruany VL; O'Connor CM; Krishnan RR; Hennekens CH
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):163-4. PubMed ID: 16211204
    [No Abstract]   [Full Text] [Related]  

  • 45. Do triptan antimigraine medications interact with SSRI/SNRI antidepressants? What does your decision support system say?
    Kogut SJ
    J Manag Care Pharm; 2011 Sep; 17(7):547-51. PubMed ID: 21870895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs--important considerations of adverse interactions especially for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome.
    Theoharides TC; Asadi S; Weng Z; Zhang B
    J Clin Psychopharmacol; 2011 Aug; 31(4):403-5. PubMed ID: 21694612
    [No Abstract]   [Full Text] [Related]  

  • 47. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
    Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
    Circulation; 2010 Dec; 122(24):2619-33. PubMed ID: 21060077
    [No Abstract]   [Full Text] [Related]  

  • 48. Risk of Major Adverse Cardiovascular Events Associated with Concomitant Use of Antidepressants and Non-steroidal Anti-inflammatory Drugs: A Retrospective Cohort Study.
    Jeong HE; Oh IS; Kim WJ; Shin JY
    CNS Drugs; 2020 Oct; 34(10):1063-1074. PubMed ID: 32737794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluoxetine: new indication. Depression in children: too many uncertainties.
    Prescrire Int; 2008 Oct; 17(97):186-7. PubMed ID: 19534039
    [No Abstract]   [Full Text] [Related]  

  • 50. Augmenting selective serotonin reuptake inhibitors with clomipramine in obsessive-compulsive disorder: benefits and risks.
    Andrade C
    J Clin Psychiatry; 2013 Dec; 74(12):e1128-33. PubMed ID: 24434100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study.
    Patel R; Reiss P; Shetty H; Broadbent M; Stewart R; McGuire P; Taylor M
    BMJ Open; 2015 Dec; 5(12):e008341. PubMed ID: 26667012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serotonin syndrome with sertraline and indomethacin.
    Coster S; Visser MH; Touw DJ; Wirtz PW
    J Clin Psychopharmacol; 2010 Aug; 30(4):468-70. PubMed ID: 20631569
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study.
    Chen VC; Ng MH; Chiu WC; McIntyre RS; Lee Y; Lin TY; Weng JC; Chen PC; Hsu CY
    PLoS One; 2017; 12(3):e0173005. PubMed ID: 28257449
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concomitant use of SSRIs, NSAIDs/aspirin and gastroprotective drugs among residents of long-term care facilities: a medical record review.
    Bell JS; Taipale HT; Soini H; Pitkälä KH
    Clin Drug Investig; 2011; 31(5):337-44. PubMed ID: 21366362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.
    Venerito M; Schneider C; Costanzo R; Breja R; Röhl FW; Malfertheiner P
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1464-1471. PubMed ID: 29655196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective serotonin re-uptake inhibitors and the risk of bleeding.
    Weinrieb RM; Auriacombe M; Lynch KG; Lewis JD
    Expert Opin Drug Saf; 2005 Mar; 4(2):337-44. PubMed ID: 15794724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
    Bérard A; Zhao JP; Sheehy O
    BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Rheumatoid arthritis and depression].
    Kellner H
    MMW Fortschr Med; 2009 Dec; 151(51-52):49. PubMed ID: 20088325
    [No Abstract]   [Full Text] [Related]  

  • 59. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactions with drugs used in the treatment of depressive illness.
    D'Arcy PF; Griffin JP
    Adverse Drug React Toxicol Rev; 1995; 14(4):211-31. PubMed ID: 8845455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.